勃起功能障礙治療的全球市場 - 熱門市場（2024-2029）

勃起功能障礙 (ED) 是指持續或反覆無法維持陰莖勃起以進行令人滿意的性活動或性交。ED 通常被稱為陽痿，被認為是最常見的男性性健康疾病之一。

2023年，全球勃起功能障礙治療市場規模為47.2751億美元，複合年增長率為-0.94%。這一市場規模主要是由勃起功能障礙和相關慢性疾病（如糖尿病、良性前列腺增生、前列腺癌和心血管疾病）患病率上升所推動的，而這些疾病反過來又可能成為該疾病發展的高風險因素。成為勃起功能障礙治療市場的重要因素。

2023年，北美和歐洲佔據市場主導地位，市佔率分別為33.63%和29.05%。就預測期內的收入而言，亞太地區預計將成為成長最快的勃起功能障礙治療市場，複合年增長率為 2.70%。

從產品來看，裝備產業以醫藥產業為主，市佔率為79.08%，裝備產業市佔率為20.92%。然而，在預測期內，設備領域可能會出現最高的增量和絕對成長率，分別為 2.5258 億美元和 25.54%。

勃起功能障礙藥物的給藥途徑（RoA）細分為口服藥物、陰莖注射和外用藥物。在這三個細分市場中，由於品牌藥物的採用率很高，口服藥物佔比最大。整體來看，口服藥物佔92.57%，其次是陰莖注射藥物，佔4.70%，外用藥物佔2.73%。

意識的提高、患者尋求醫療援助來治療和管理疾病的意願不斷增強，以及推薦使用藥物和設備治療勃起功能障礙的有利指南的不斷出現，預計將推動預測期內的市場增長。有望促進增長。

該報告研究了全球勃起功能障礙治療市場，並概述了市場、區域趨勢以及參與市場的公司概況。

目錄

第一章 勃起功能障礙治療市場概述

第二章 勃起功能障礙治療市場

第三章勃起功能障礙治療市場區隔數據

第四章 主要地區概況

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東/非洲

第五章勃起功能障礙治療市場前景與機遇

• 勃起功能障礙治療市場機會與趨勢
• 勃起功能障礙治療市場驅動因素
• 限制勃起功能障礙治療市場的因素

第六章 勃起功能障礙治療產業概述

• 勃起功能障礙治療市場 - 競爭格局
• 勃起功能障礙治療市場－主要供應商概況
• 勃起功能障礙治療市場—其他知名供應商
• 勃起功能障礙治療市場—關鍵策略建議

第7章附錄

REPORT OVERVIEW

This report offers market size & forecast data for the global erectile dysfunction treatment market. The revenue generated from the sale of drugs & devices is included in the report. This report provides a comprehensive and current market scenario of the global erectile dysfunction treatment market, including the global erectile dysfunction treatment market size, anticipated market forecast, relevant market segmentations, and industry trends.

The study considers a detailed scenario of the present global erectile dysfunction treatment market and its market dynamics for 2024-2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

Erectile dysfunction (ED) is the condition that is a persistent or recurrent inability to attain and maintain penile erection sufficient to permit satisfactory sexual activity and intercourse. ED is commonly referred to as impotence and is considered one of the most common male sexual health disorders.

KEY HIGHLIGHTS

• The global erectile dysfunction treatment market was valued at $4,727.51 million in 2023 and registered a negative CAGR of -0.94%. The market reach is mainly attributed to the rising prevalence of erectile dysfunction and associated chronic diseases such as diabetes, benign prostate hyperplasia, prostate cancer, and CVDs, which can, in turn, pose high-risk factors for the occurrence of disease, are critical factors for the erectile dysfunction treatment market.
• In 2023, North America and Europe dominated the market with a market share of 33.63% and 29.05%, respectively. APAC is expected to be the fastest-growing market for erectile dysfunction treatment in terms of revenue during the forecast period, with a CAGR of 2.70%.
• Based on product, the drugs segment dominated the market over the devices segment and accounted for a market share of 79.08%, whereas the devices segment accounted for a 20.92% share. However, during the forecast period, the devices segment will likely witness the highest incremental and absolute growth of $252.58 million and 25.54%, respectively.
• The route of administration (RoA) segment of ED drugs is sub-segmented into oral medications, penile injections, and topical drugs. Among the three sub-segments, oral drugs occupied the largest share, which is attributed to the high adoption of branded drugs. Overall, 92.57% was occupied by oral drugs, followed by penile injections at 4.70% and topical drugs at 2.73%.
• Rising awareness, growing patient willingness to demand medical assistance for disease care and management, and the increasing presence of favorable guidelines that recommend the use of drugs and devices for the treatment of ED are expected to propel the market growth during the forecast period.
• Bayer, Pfizer, Eli Lilly and Company, Coloplast, and Boston Scientific are some of the leading players currently dominating the global erectile dysfunction treatment market. The major players focus on strategic acquisitions and collaborations with emerging players to enter the ED treatment market and gain access to commercially launched products.

VENDORS LIST

• Bayer
• Pfizer
• Coloplast
• Eli Lilly and Company
• Boston Scientific
• Teva Pharma
• Viatris
• Dong-A Socio
• Vivus
• Cristalia
• Dr.Reddy's
• Aurobindo
• Seelos Therapeutics
• Menarini Group
• GSK plc
• Futura Medical
• Sanofi
• Cipla
• Lupin
• Advanz Pharma
• Sandoz
• IX Biopharma
• Domier Medtech
• Zephyr Surgical Implants
• Augusta Medical Systems
• Metuchen Pharmaceuticals
• SK Chemicals
• Endo International
• Ferring Pharmaceuticals
• Alembic Pharmaceuticals
• Guangzhou Pharmaceuticals
• Launch Medical
• Bonro Medical
• Owen Mumford
• Direx Group
• Zimmer Medizin Systems
• MTS Medical UG
• Medispec
• Inceler Medical
• NOVAmedtek
• Wikkon
• Top Quality Group
• Promedon
• Timm Medical Technologies
• Global Life Technologies
• Urology Health Store
• Hims

REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST

• Product type

Drugs

Route of Administration

• Oral Drugs
• Penile Injections
• Topical Drugs

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Portals

Devices

Type

• Penile Implants
• Vacuum Construction Devices
• Shock Wave Therapy
• Others

MARKET STRUCTURE

• Market Dynamics
• Competitive Landscape of ED Treatment Market
• Key Vendors
• Other Prominent Vendors

APPENDIX

• Research Methodology
• Abbreviations
• About Arizton

TABLE OF CONTENTS

CHAPTER - 1: ED Treatment Market Overview

• Executive Summary
• Key Findings

CHAPTER - 2: ED Treatment Market

• GLOBAL: Projected Revenue of ED Treatment Market (2023-2029; $Millions)

CHAPTER - 3: ED Treatment Market Segmentation Data

• GLOBAL: Projected Revenue by Product type (2022-2028; $ Millions)

Drugs

Route of Administration

• Oral Drugs
• Penile Injections
• Topical Drugs

Distribution Channels

• Retail Stores
• Hospital Pharmacies
• Online Portals

Devices

Type

• Penile Implants
• Vacuum Construction Devices
• Shock Wave Therapy
• Others

CHAPTER - 4: Key Regions Overview

• North America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in US
  • Projected Revenue of ED Treatment Market in Canada
• Europe: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in UK
  • Projected Revenue of ED Treatment Market in Germany
  • Projected Revenue of ED Treatment Market in France
  • Projected Revenue of ED Treatment Market in Italy
  • Projected Revenue of ED Treatment Market in Spain
• APAC: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in Japan
  • Projected Revenue of ED Treatment Market in China
  • Projected Revenue of ED Treatment Market in India
• Latin America: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in Brazil
  • Projected Revenue of ED Treatment Market in Mexico
  • Projected Revenue of ED Treatment Market in Argentina
• Middle East & Africa: Projected Revenue of ED Treatment Market (2023-2029; $Millions)
  • Projected Revenue of ED Treatment Market in Saudi Arabia
  • Projected Revenue of ED Treatment Market in South Africa
  • Projected Revenue of ED Treatment Market in Turkey

CHAPTER - 5: ED Treatment Market Prospects & Opportunities

• ED Treatment Market Opportunities & Trends
• ED Treatment Market Drivers
• ED Treatment Market Constraints

CHAPTER - 6: ED Treatment Industry Overview

• ED Treatment Market - Competitive Landscape
• ED Treatment Market - Key Vendor Profiles
• ED Treatment Market - Other Prominent Vendors
• ED Treatment Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

• Research Methodology
• Abbreviations
• About Arizton

List Of Exhibits

LIST OF EXHIBITS

Exhibit 1: Projected Revenues of ED Treatment in Global (2023-2029; $ Mn)

Exhibit 2: Projected Revenue of ED Treatment by Drugs (2023-2029; $ Mn)

Exhibit 3: Projected Revenue of ED Treatment by Oral Drugs ($ Mn)

Exhibit 4: Projected Revenues of ED Treatment by Penile Injections (2023-2029; $ Mn)

Exhibit 5: Projected Revenues of ED Treatment by Topical Drugs (2023-2029; $ Mn)

Exhibit 6: Projected Revenues of ED Treatment by Retail Stores (2023-2029; $ Mn)

Exhibit 7: Projected Revenues of ED Treatment by Hospital Pharmacies (2023-2029; $ Mn)

Exhibit 8: Projected Revenues of ED Treatment by Online Portals (2023-2029; $ Mn)

Exhibit 9: Projected Revenue of ED Treatment by Devices (2023-2029; $ Mn)

Exhibit 10: Projected Revenues of ED Treatment by Penile Implants (2023-2029; $ Mn)

Exhibit 11: Projected Revenues of ED Treatment by Vacuum Construction Devices

(2023-2029; $ Mn)

Exhibit 12: Projected Revenues of ED Treatment by Shock Wave Therapy (2023-2029; $ Mn)

Exhibit 13: Projected Revenues of ED Treatment by Others (2023-2029; $ Mn)

Exhibit 14: Projected Revenues of ED Treatment in North America (2023-2029; $ Mn)

Exhibit 15: Projected Revenues of ED Treatment in US (2023-2029; $ Mn)

Exhibit 16: Projected Revenues of ED Treatment in Canada (2023-2029; $ Mn)

Exhibit 17: Projected Revenues of ED Treatment in Europe (2023-2029; $ Mn)

Exhibit 18: Projected Revenues of ED Treatment in UK (2023-2029; $ Mn)

Exhibit 19: Projected Revenues of ED Treatment in Germany (2023-2029; $ Mn)

Exhibit 20: Projected Revenues of ED Treatment in France (2023-2029; $ Mn)

Exhibit 21: Projected Revenues of ED Treatment in Italy (2023-2029; $ Mn)

Exhibit 22: Projected Revenues of ED Treatment in Spain (2023-2029; $ Mn)

Exhibit 23: Projected Revenues of ED Treatment in APAC (2023-2029; $ Mn)

Exhibit 24: Projected Revenues of ED Treatment in Japan (2023-2029; $ Mn)

Exhibit 25: Projected Revenues of ED Treatment in China (2023-2029; $ Mn)

Exhibit 26: Projected Revenues of ED Treatment in India (2023-2029; $ Mn)

Exhibit 27: Projected Revenues of ED Treatment in Latin America (2023-2029; $ Mn)

Exhibit 28: Projected Revenues of ED Treatment in Brazil (2023-2029; $ Mn)

Exhibit 29: Projected Revenues of ED Treatment in Mexico (2023-2029; $ Mn)

Exhibit 30: Projected Revenues of ED Treatment in Argentina (2023-2029; $ Mn)

Exhibit 31: Projected Revenues of ED Treatment in MEA (2023-2029; $ Mn)

Exhibit 32: Projected Revenues of ED Treatment in Saudi Arabia (2023-2029; $ Mn)

Exhibit 33: Projected Revenues of ED Treatment in South Africa (2023-2029; $ Mn)

Exhibit 34: Projected Revenues of ED Treatment in Turkey (2023-2029; $ Mn)

List Of Tables

LIST OF TABLES

Table 1: Key Market Trends in ED Treatment Market

Table 2: Key Market Enablers in ED Treatment Market

Table 3: Key Market Constraints in ED Treatment Market

Table 4: Strategic Recommendations in ED Treatment Market